跳至主要内容
临床试验/CTRI/2020/03/023836
CTRI/2020/03/023836尚未招募不适用

CLINICO EPIDEMIOLOGICAL PROFILE OF CHILDREN WITH MYCOPLASMA PNEUMONIA AMONG COMMUNITY ACQUIRED PNEUMONIA.

Institute of child health and hospital for children1 个研究点 分布在 1 个国家目标入组 268 人开始时间: 2021年1月2日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
268
试验地点
1
主要终点
This study aims to identify any specific clinical markers that helps in the diagnosis of mycoplasma and reduce the usage of unwarranted and empirical macrolides in community acquired pneumonia cases.

研究概览

简要总结

Children between 2 months and 12 yrs of age with bronchopneumonia fullfilling the revised WHO criteria are recruited under the study. Induced sputum specimen will be taken and analysed for the prevalence of mycoplasma among CAP based on culture. Its sensitivity pattern for macrolides will also be analysed based on PCR.

研究设计

研究类型
Observational

入排标准

年龄范围
2.00 Month(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • 1.All children between 2 months to 12 years of age admitting with symptoms suggestive of community acquired pneumonia as per the WHO criteria (Cough, cold, fast breathing and chest indrawing.

排除标准

  • 1.Children with aspiration pneumonia with neurodevelopmental delay 2.Children with hospital acquired pneumonia( pneumonia developing 72 hrs after admission or within 7 days of discharge) 3.Children with co morbid conditions prone to cause recurrent pneumonias(congenital heart diseases, airway anomalies, cystic fibrosis,congenital or acquired immunodeficiency.

结局指标

主要结局

This study aims to identify any specific clinical markers that helps in the diagnosis of mycoplasma and reduce the usage of unwarranted and empirical macrolides in community acquired pneumonia cases.

时间窗: February 2020 to february 2021

次要结局

  • This study also aims to identify the sensitivity pattern of the mycoplasma pneumonia to macrolides.(February 2020 to february 2021)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验